Abstract
Endocrine disrupting chemicals (EDCs) affect the internal endocrine functions in human and thus effective analytical methods have been developed in recent years. In particular, quantification of EDCs in human biological fluids is essential to obtain direct information about the health risk associated with exposure to these compounds. High performance liquid chromatography (HPLC) has often been applied to the measurement of relatively polar EDCs for instance bisphenol A, phytoestrogen and phthalte metabolites in human biological samples. For detection of EDCs by HPLC, several detection methods such as ultraviolet, fluorescence, electrochemical detection and mass spectrometry are used. These detection methods are selected appropriately in consideration to their sensitivity and selectivity, and characteristics of analytes. Recently, the use of tandem mass spectrometry has increased owing to its excellent specificity. These HPLC methods are used in combination with a suitable sample preparation technique to remove large amounts of complex matrices that interfere with the detection of trace amounts of EDCs in biological fluids and to obtain sufficiently clean chromatogram. We summarized the detection and preparation method for the HPLC determination of EDCs and their metabolites in various human biological fluids such as blood, urine and breast milk.
Keywords: Endocrine disrupting chemicals, High performance liquid chromatography, Pretreatment, Detection method
Current Analytical Chemistry
Title: Human Biomonitoring of Endocrine Disrupting Chemicals by HPLC Methods
Volume: 2 Issue: 1
Author(s): Naoya Kishikawa, Kaname Ohyama and Naotaka Kuroda
Affiliation:
Keywords: Endocrine disrupting chemicals, High performance liquid chromatography, Pretreatment, Detection method
Abstract: Endocrine disrupting chemicals (EDCs) affect the internal endocrine functions in human and thus effective analytical methods have been developed in recent years. In particular, quantification of EDCs in human biological fluids is essential to obtain direct information about the health risk associated with exposure to these compounds. High performance liquid chromatography (HPLC) has often been applied to the measurement of relatively polar EDCs for instance bisphenol A, phytoestrogen and phthalte metabolites in human biological samples. For detection of EDCs by HPLC, several detection methods such as ultraviolet, fluorescence, electrochemical detection and mass spectrometry are used. These detection methods are selected appropriately in consideration to their sensitivity and selectivity, and characteristics of analytes. Recently, the use of tandem mass spectrometry has increased owing to its excellent specificity. These HPLC methods are used in combination with a suitable sample preparation technique to remove large amounts of complex matrices that interfere with the detection of trace amounts of EDCs in biological fluids and to obtain sufficiently clean chromatogram. We summarized the detection and preparation method for the HPLC determination of EDCs and their metabolites in various human biological fluids such as blood, urine and breast milk.
Export Options
About this article
Cite this article as:
Kishikawa Naoya, Ohyama Kaname and Kuroda Naotaka, Human Biomonitoring of Endocrine Disrupting Chemicals by HPLC Methods, Current Analytical Chemistry 2006; 2 (1) . https://dx.doi.org/10.2174/157341106775197394
DOI https://dx.doi.org/10.2174/157341106775197394 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein and Peptide Biopharmaceuticals: An Overview
Protein & Peptide Letters Architectures and Mechanical Properties of Drugs and Complexes of Surface-Active Compounds at Air-Water and Oil-Water Interfaces
Current Drug Discovery Technologies Nardilysin, A Basic Residues Specific Metallopeptidase That Mediates Cell Migration and Proliferation
Protein & Peptide Letters Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design Prostate Cancer Horizons in the Development of Novel Anti-Cancer Strategies
Current Medicinal Chemistry - Anti-Cancer Agents Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment
Current Cancer Drug Targets Evaluation of In Vivo Efficacy of Aqueous Extract of Aerial Parts of Cynodon dactylon in Rats with Simultaneous Type 2 Diabetes and Hypertension
Current Bioactive Compounds The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Reviews on Recent Clinical Trials Pancreatic β-cell Glucose Toxicity in Type 2 Diabetes Mellitus
Current Diabetes Reviews Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Angiotensin Peptides and Lung Cancer
Current Cancer Drug Targets Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology Alzheimer’s Disease, Astrocytes and Kynurenines
Current Alzheimer Research DNA Methylation, An Epigenetic Mode of Gene Expression Regulation in Reproductive Science
Current Pharmaceutical Design Clinical Application of Ghrelin
Current Pharmaceutical Design Influence of Lifestyle Measures on Hypertriglyceridaemia
Current Drug Targets Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Comparison Between the Effects of Bupivacaine and Levobupivacaine for Spinal Anesthesia on QT Dispersion
Cardiovascular & Hematological Disorders-Drug Targets The Role of Probiotics and Prebiotics in Osteolastogenesis and Immune Relevance
Current Medicinal Chemistry Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry